Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR)

Medical Science Monitor

Volumn 14, Issue 2, 2008, Pages

  Brummett, Beverly H ^a   Boyle, Stephen H ^a   Siegler, Ilene C ^a   Züchner, Stephan ^b   Ashley Koch, Allison ^a   Williams, Redford B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Allelic variation; Genetics; Lipoprotien; Stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CHOLESTEROL; DOPAMINE; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION;

AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; BODY MASS INDEX; CORONARY DISEASE; DNA PRIMERS; HUMANS; LIPIDS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 39349107191     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sabol SZ, Hu S, Hamer D: A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics, 1998; 103: 273-79
2. Jacob CP, Muller J, Schmidt M et al: Cluster B personality disorders are associated with allelic variation of monoamine oxidase A acitivity. Neuropsychopharmacology, 2005; 4: 1-8
3. Huang Y, Cate SP, Battistuzzi C et al: An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology, 2004; 29: 1498-505
4. Deckert J, Catalano M, Syagailo YV et al: Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics, 1999; 8: 621-24
5. Denney RM, Koch H, Craig IW: Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Human Genetics, 1999; 105: 542-51
6. Youdim MBH, Finberg JPM, Tipton KF: Monoamine oxidase In: Catecholamine II. Edited by Trendelengurg U, Weiner U. Berlin: Springer-Verlag, 1988; 119-92
7. Shih JC, Chen K, Ridd MJ: Monoamine oxidase: from genes to behavior. Annu Rev Neurosci, 1999; 22: 197-217
8. Manuck SB, Flory JD, Ferrell RE et al: A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res, 2000; 95: 9-23
9. Caspi A, McClay J, Moffitt TE et al: Role of genotype in the cycle of violence in maltreated children. Science, 2002; 297: 851-54
10. Foley DL, Eaves LJ, Wormley B et al: Childhood adversity, monoamine oxidase A genotype, and risk for conduct disorder. Arch Gen Psychiatry, 2004; 61: 738-44
11. Contini V, Marques FZC, Garcia CED et al: MAOA-uVNTR Polymorphism in a Brazilian Sample: Further support for the association with impulsive behaviors and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet, 2006; 141B: 305-8
12. Lawson DC, Turic D, Langley K et al: Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet, 2003; 116B: 84-89
13. Preisig M, Ferrero F, Malafosse A: Monoamine oxidase a and trytophan hydroxylase gene polymorphisms: are they associated with bipolar disorder? Am J Pharmacogenomics, 2005; 5: 45-52
14. Du L, Faludi G, Palkovits M et al: High activity-related allele of MAOA gene associated with depressed suicide in males. Neuroreport, 2002; 13: 1195-98
15. Brummett BH, Krystal AD, Siegler IC et al: Associations of a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med, 2007; 69: 396-401
16. Need AC, Ahmadi KR, Spector TD, Goldstein DB: Obesity is associated with genetic variants that alter dompamine availability. Ann Hum Genet, 2006; 70: 293-303
17. Ducci F, Newman TK, Funt S et al: A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Mol Psychiatry, 2006; 11: 856-66
18. Fuemmeler BF, Agurs-Collins T, McClernon FJ et al: Genes implicated in serotonergic and dopaminergic functioning interact with gender and ethnicity to predict BMI categories. Obes Res, in press
19. Camarena B, Santiago H, Aguilar A et al: Family-based association study between the monoamine oxidase A gene and obesity: Implications for psychopharmacogenetic studies. Neuropsychobiology, 2004; 49: 126-29
20. Benjamin D, Van Bakel I, Craig IW: A novel expression based approach for assessing the inactivation status of human X-linked genes. Eur J Hum Genet, 2000; 8: 103-8
21. Carrel L, Willard H: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature, 2005; 434: 400-4
22. Rimmler J, McDowell JG, Slotterback BD et al: Development of a data coordinating center (DCC): Data quality control for complex disease studies. Am J Hum Genet, 1998; 63: 240
23. Bray GA: Contemporary Diagnosis and Management of Obesity. Newton, PA: Handbooks in Health Care Co., 1998
24. Williams RB, Marchuk DA, Gadde KM et al: Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology, 2003; 28: 533-41
25. nd ed. Hillsdale, NJ: Lawerence Erlbaum Associates, 1988
26. Visentin V, Prevot D, De Saint Front VD et al: Alteration of amine oxidase activity in the adipose tissue of obese subjects. Obes Res, 2004; 12: 547-55
27. Kiive E, Merenakk L, Harro M, Harro J: Changes in platelet monoamine oxidase activity, cholesterol levels and hyperactive behavior in adolescents over a period of three years. Neuroscience Letters, 2005; 384: 310-15
28. Ramos EJ, Meguid MM, Campos AC, Coelho JC: Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation. Nutrition, 2005; 21: 269-79
29. Brindley DN, McCann BS, Niaura R et al: Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism: Clinical & Experimental, 1993; 42: 3-15
30. Stoney CM, Hughes JW, Kuntz KK et al: Cardiovascular stress responses among Asian Indian and European American women and men. Ann Behav Med, 2002; 24: 113-21
31. Brindley DN, Salter AM: Hormonal regulation of the hepatic low density lipoprotein receptor and the catabolism of low density lipoproteins: Relationship with the secretion of very low density lipoproteins. Prog Lipid Res, 1991; 30: 349-60
32. Salter AM, Fisher SC, Brindley DN: Binding of low-density lipoprotein to monolayer cultures of rat hepatocytes is increased by insulin and decreased by dexamethasone FEBS Lett, 1987; 220: 159-62